X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Novartis with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs NATCO PHARMA - Comparison Results

NOVARTIS    Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS NATCO PHARMA NOVARTIS/
NATCO PHARMA
 
P/E (TTM) x 356.8 16.7 2,132.8% View Chart
P/BV x 39.6 18.0 219.3% View Chart
Dividend Yield % 1.2 0.6 182.2%  

Financials

 NOVARTIS   NATCO PHARMA
EQUITY SHARE DATA
    NOVARTIS
Mar-18
NATCO PHARMA
Mar-14
NOVARTIS/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs758877 86.4%   
Low Rs579424 136.7%   
Sales per share (Unadj.) Rs228.4223.4 102.2%  
Earnings per share (Unadj.) Rs31.731.1 102.2%  
Cash flow per share (Unadj.) Rs32.840.3 81.4%  
Dividends per share (Unadj.) Rs10.005.00 200.0%  
Dividend yield (eoy) %1.50.8 194.5%  
Book value per share (Unadj.) Rs297.1219.5 135.4%  
Shares outstanding (eoy) m24.6933.07 74.7%   
Bonus/Rights/Conversions -PA-  
Price / Sales ratio x2.92.9 100.6%   
Avg P/E ratio x21.120.9 100.6%  
P/CF ratio (eoy) x20.416.1 126.4%  
Price / Book Value ratio x2.23.0 75.9%  
Dividend payout %31.516.1 195.8%   
Avg Mkt Cap Rs m16,50521,504 76.8%   
No. of employees `0000.7NA-   
Total wages/salary Rs m1,4451,128 128.2%   
Avg. sales/employee Rs Th8,441.3NM-  
Avg. wages/employee Rs Th2,163.6NM-  
Avg. net profit/employee Rs Th1,173.1NM-  
INCOME DATA
Net Sales Rs m5,6397,389 76.3%  
Other income Rs m1,718167 1,028.3%   
Total revenues Rs m7,3577,556 97.4%   
Gross profit Rs m-631,793 -3.5%  
Depreciation Rs m25304 8.3%   
Interest Rs m55366 15.1%   
Profit before tax Rs m1,5751,290 122.1%   
Minority Interest Rs m046 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m792309 256.4%   
Profit after tax Rs m7841,027 76.3%  
Gross profit margin %-1.124.3 -4.6%  
Effective tax rate %50.323.9 210.0%   
Net profit margin %13.913.9 99.9%  
BALANCE SHEET DATA
Current assets Rs m9,5223,681 258.6%   
Current liabilities Rs m3,2963,123 105.5%   
Net working cap to sales %110.47.6 1,460.5%  
Current ratio x2.91.2 245.0%  
Inventory Days Days3789 40.9%  
Debtors Days Days2859 48.4%  
Net fixed assets Rs m467,685 0.6%   
Share capital Rs m123331 37.3%   
"Free" reserves Rs m7,2136,670 108.1%   
Net worth Rs m7,3367,259 101.1%   
Long term debt Rs m0955 0.0%   
Total assets Rs m11,10511,957 92.9%  
Interest coverage x29.54.5 652.0%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.50.6 82.2%   
Return on assets %7.611.7 64.8%  
Return on equity %10.714.2 75.5%  
Return on capital %22.220.7 107.2%  
Exports to sales %039.4 0.0%   
Imports to sales %05.7 0.0%   
Exports (fob) Rs mNA2,908 0.0%   
Imports (cif) Rs mNA421 0.0%   
Fx inflow Rs m613,445 1.8%   
Fx outflow Rs m3,630703 516.5%   
Net fx Rs m-3,5702,743 -130.2%   
CASH FLOW
From Operations Rs m1,6101,440 111.8%  
From Investments Rs m687-1,089 -63.1%  
From Financial Activity Rs m-2,677-353 758.9%  
Net Cashflow Rs m-380-1 25,476.5%  

Share Holding

Indian Promoters % 0.0 52.0 -  
Foreign collaborators % 75.0 1.5 5,102.0%  
Indian inst/Mut Fund % 2.0 7.8 25.5%  
FIIs % 1.6 16.6 9.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.5 26.0 82.7%  
Shareholders   41,647 25,395 164.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   ABBOTT INDIA  ALKEM LABORATORIES  DIVIS LABORATORIES  PIRAMAL ENTERPRISES  ALEMBIC PHARMA  

Compare NOVARTIS With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Healthcare & Metal Stocks Gain(09:30 am)

Asian share markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 1.5% while the Hang Seng is up 1.2%.

Related Views on News

NATCO PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 93.3% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (up 93.3% YoY). Sales on the other hand came in at Rs 5 bn (up 21.0% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NOVARTIS Announces Quarterly Results (1QFY19); Net Profit Up 42.2% (Quarterly Result Update)

Jul 30, 2018 | Updated on Jul 30, 2018

For the quarter ended June 2018, NOVARTIS has posted a net profit of Rs 100 m (up 42.2% YoY). Sales on the other hand came in at Rs 1 bn (up 20.3% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

In a Crisis, if Petrol Prices Hit Rs 100, This Stock Could Be a Good Buy(The 5 Minute Wrapup)

Sep 6, 2018

The rise in the crude oil price is a major reason for the fall in the market. If crude oil prices keep on rising, what will happen to stocks?

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

The Secret Of Mirae Asset India Equity Fund's Increasing Popularity(Outside View)

Sep 7, 2018

The prudent investment strategies followed at the fund house has helped Mirae Asset India Equity Fund earn a tag of being a consistent performer, which is in turn gaining popularity among investors.

Hurricanes Threaten Oil Spike, but the Saudis are Selling...(Vivek Kaul's Diary)

Sep 6, 2018

Oil prices are rising and could go even more higher amid rising tensions in Middle East.

Should You Be Worried About the Rising Dollar?(Chart Of The Day)

Sep 7, 2018

While the rupee has deprecated by about 5% annually since 1990 against the dollar, the BSE Sensex has returned 14% annually in the same period.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Sep 19, 2018 12:43 PM

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS 8-QTR ANALYSIS

COMPARE NOVARTIS WITH

MARKET STATS